These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17094003)

  • 1. Evaluation of hearing and cochlear function by DPOAE and audiometric tests in patients with ankylosing spondilitis.
    Dagli M; Sivas Acar F; Karabulut H; Eryilmaz A; Erkol Inal E
    Rheumatol Int; 2007 Apr; 27(6):511-6. PubMed ID: 17094003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cochlear involvement by distortion product otoacoustic emission in Behçet's disease.
    Dagli M; Eryilmaz A; Tanrikulu S; Aydin A; Gonul M; Gul U; Gocer C
    Auris Nasus Larynx; 2008 Sep; 35(3):333-7. PubMed ID: 17996415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of high-frequency hearing loss and outer hair cell function of the cochlea in patients with psoriasis: a case-control study.
    Vir D; Sharma P; Mahajan R; Dogra S; Bakshi J; Panda NK
    Clin Exp Dermatol; 2019 Jul; 44(5):520-523. PubMed ID: 30280411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [DPOAE in tinnitus patients with cochlear hearing loss considering hyperacusis and misophonia].
    Sztuka A; Pośpiech L; Gawron W; Dudek K
    Otolaryngol Pol; 2006; 60(5):765-72. PubMed ID: 17263252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further efforts to predict pure-tone thresholds from distortion product otoacoustic emission input/output functions.
    Gorga MP; Neely ST; Dorn PA; Hoover BM
    J Acoust Soc Am; 2003 Jun; 113(6):3275-84. PubMed ID: 12822800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distortion product otoacoustic emissions and sensorineural hearing loss.
    Moulin A; Bera JC; Collet L
    Audiology; 1994; 33(6):305-26. PubMed ID: 7741665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hearing loss in patients with ankylosing spondylitis.
    Eryilmaz A; Dagli M; Karabulut H; Sivas Acar F; Erkol Inal E; Gocer C
    J Laryngol Otol; 2007 Sep; 121(9):845-9. PubMed ID: 17125576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of auditory and cochlear functions in ankylosing spondylitis patients according to the site of involvement.
    Karataş D; Doğan İ; Ekinci A; Yetiş A; Özcan M
    Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):3875-3881. PubMed ID: 28889257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term changes of hearing and distortion product otoacoustic emissions in sudden sensorineural hearing loss.
    Park H; Lee Y; Park M; Kim J; Na B; Shin J
    Otol Neurotol; 2010 Aug; 31(6):862-6. PubMed ID: 20601916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of glycerol test in Meniere's disease with pure tone audiometry and distortion product otoacoustic emission].
    Jabłonka A; Pośpiech L; Orendorz-Fraczkowska K
    Otolaryngol Pol; 2003; 57(5):731-7. PubMed ID: 14994621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibility for quantitative and frequency-specific assessment of auditory threshold with otoacoustic emissions].
    Dreher A; Suckfüll M; Schneeweiss S; Schorn K
    Laryngorhinootologie; 1997 Jan; 76(1):2-7. PubMed ID: 9156504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distortion product otoacoustic emission findings in Behçet's disease and rheumatoid arthritis.
    Bayazit YA; Yilmaz M; Gunduz B; Altinyay S; Kemaloglu YK; Onder M; Gurer MA
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(4):233-8. PubMed ID: 17409782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outer hair cell activity of the cochlea in patients with iron deficiency anemia.
    Cetin T; Yetiser S; Cekin E; Durmus C; Nevruz O; Oktenli C
    Auris Nasus Larynx; 2004 Dec; 31(4):389-94. PubMed ID: 15571912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence of early cochlear damage in young patients with type 1 diabetes detected by distortion product otoacoustic emissions.
    Botelho CT; Carvalho SA; Silva IN
    Int J Audiol; 2014 Jun; 53(6):402-8. PubMed ID: 24564623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DPOAE-grams in patients with acute tonal tinnitus.
    Gouveris H; Maurer J; Mann W
    Otolaryngol Head Neck Surg; 2005 Apr; 132(4):550-3. PubMed ID: 15806043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Audiological findings in patients with ankylosing spondylitis.
    Alatas N; Yazgan P; Oztürk A; San I; Iynen I
    J Laryngol Otol; 2005 Jul; 119(7):534-9. PubMed ID: 16175978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of distortion product otoacoustic emission with tinnitus.
    Ami M; Abdullah A; Awang MA; Liyab B; Saim L
    Laryngoscope; 2008 Apr; 118(4):712-7. PubMed ID: 18176342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.